Dow Up 0.26% Nasdaq Down 1.07%

Epizyme, Inc. (EPZM)

-NMS
27.74 1.07(3.71%) Sep 15, 4:00PM EDT
Prev Close:28.81
Open:28.67
Bid:19.96 x 100
Ask:37.04 x 100
1y Target Est:43.33
Beta:3.513
Earnings Date:Oct 20 - Oct 24 (Est.)
Day's Range:27.56 - 28.84
52wk Range:18.10 - 42.71
Volume:176,354
Avg Vol (3m):332,056
Market Cap:931.59M
P/E (ttm):N/A
EPS (ttm):-0.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
EPZMDown 3.71%931.59M
GSK112.85B
NVS228.50B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):14.30
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.62
Quarterly EPS Est (Sep-14) :-0.56
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Epizyme, Inc., a clinical stage biopharmaceutical company, discovers and develops personalized therapeutics for patients with genetically defined cancers. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback